News | May 12, 2023
Gilead acquires XinThera to strengthen pipeline in oncology
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
The return profile of NCDs is linked to BBL share price subject to minimum IRR of 12%.
The business and product range of Ipca and that of Unichem complements each others business and product range
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
Subscribe To Our Newsletter & Stay Updated
